Download PDF
J Am Acad Audiol 2021; 32(09): 616-624
DOI: 10.1055/s-0042-1744105
Case Report

Audiovestibular Dysfunction in Siblings with Charcot–Marie–Tooth Disease 4F: A Case Series

Prashasti Poovaiah 
1   Department of Speech Pathology & Audiology, National Institute of Mental Health & Neurosciences, Bangalore, Karnataka, India
,
Aravind Kumar Rajasekaran
1   Department of Speech Pathology & Audiology, National Institute of Mental Health & Neurosciences, Bangalore, Karnataka, India
,
Pradeep Yuvraj
1   Department of Speech Pathology & Audiology, National Institute of Mental Health & Neurosciences, Bangalore, Karnataka, India
,
Yamini K. Belur
1   Department of Speech Pathology & Audiology, National Institute of Mental Health & Neurosciences, Bangalore, Karnataka, India
,
Nalini Atchayaram
2   Department of Neurology, National Institute of Mental Health & Neurosciences, Bangalore, Karnataka, India
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background Charcot–Marie–Tooth disease type 4F (CMT4F) is an autosomal recessive disorder with symptoms presenting in early adulthood. This clinical case series demonstrates atypical findings in cervical and ocular vestibular evoked myogenic potentials (VEMP) in siblings with CMT4F.

Purpose The aim of this study was to highlight the audiovestibular test findings in CMT4F.

Research Design Case series study sample: 4 siblings, 3 of whom diagnosed with CMT4F.

Data Collection and Analysis Audiological test battery and electrophysiological tests comprising auditory brainstem response (ABR) and VEMP (both cervical and ocular) were performed in our patient population.

Results Older siblings, in whom the hearing loss was present, manifested prolonged peak V latencies in ABR. Three out of four siblings with CMT4F showed prolongation of latencies on cervical and ocular VEMP.

Conclusions In many neurodegenerative conditions, prolongation of ABR peak latencies has often been reported in the literature. There have also been a few reports of prolonged VEMP peak latencies. This article reports prolongation of only VEMP peak latencies (in both cervical and ocular recordings). The youngest sibling had prolongation of VEMP latencies, with ABR peak latencies being normal. The assumption we put forth that CMT4F may affect the vestibular pathway first requires to be tested on a larger sample and by longitudinally studying the individuals with disease condition.

Keywords

Charcot–Marie–Tooth 4F - prolonged VEMP latencies - auditory neuropathy spectrum disorder - poor speech recognition scores

Disclaimer

Any mention of a product, service, or procedure in the Journal of the American Academy of Audiology does not constitute an endorsement of the product, service, or procedure by the American Academy of Audiology.




Publication History

Received: 04 September 2020

Accepted: 08 March 2021

Article published online:
17 February 2022

© 2022. American Academy of Audiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • Reference

  • 1 Bird TD. Charcot-Marie-Tooth (CMT) Hereditary Neuropathy Overview. 1998 Sep 28 [Updated 2020 May 14]. In: Adam MP, Ardinger HH, Pagon RA. et al., eds. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1998: 1993-2020
    Google Scholar
  • 2 Stojkovic T. Hereditary neuropathies: an update. Rev Neurol (Paris) 2016; 172 (12) 775-778
    CrossrefPubMedGoogle Scholar
  • 3 Nam SHyun, Choi Byung-Ok. Clinical and genetic aspects of Charcot-Marie-Tooth disease subtypes. Precis Future Med. 2019; 3 (02) 43-68
    CrossrefGoogle Scholar
  • 4 Colomban C, Micallef J, Lefebvre MN. et al. Clinical spectrum and gender differences in a large cohort of Charcot-Marie-Tooth type 1A patients. J Neurol Sci 2014; 336 (1-2): 155-160
    CrossrefPubMedGoogle Scholar
  • 5 Pareyson D, Scaioli V, Laurà M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8 (1-2): 3-22
    CrossrefPubMedGoogle Scholar
  • 6 Boerkoel CF, Takashima H, Stankiewicz P. et al. Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 2001; 68 (02) 325-333
    CrossrefPubMedGoogle Scholar
  • 7 Takashima H, Boerkoel CF, De Jonghe P. et al. Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 2002; 51 (06) 709-715
    CrossrefPubMedGoogle Scholar
  • 8 Kovach MJ, Campbell KCM, Herman K. et al. Anticipation in a unique family with Charcot-Marie-Tooth syndrome and deafness: delineation of the clinical features and review of the literature. Am J Med Genet 2002; 108 (04) 295-303
    CrossrefPubMedGoogle Scholar
  • 9 Starr A, Michalewski HJ, Zeng FG. et al. Pathology and physiology of auditory neuropathy with a novel mutation in the MPZ gene (Tyr145->Ser). Brain 2003; 126 (Pt 7): 1604-1619
    CrossrefPubMedGoogle Scholar
  • 10 Poretti A, Palla A, Tarnutzer AA. et al. Vestibular impairment in patients with Charcot-Marie-tooth disease. Neurology 2013; 80 (23) 2099-2105
    CrossrefPubMedGoogle Scholar
  • 11 American National Standards Institute. (ANSI). Method of manual pure-tone threshold audiometry [ANSI S3.21 1978 (R-1992)]. New York: Acoustical Society of America; 1992
    Google Scholar
  • 12 Kacker SK, Basavraj V. Indian Speech, Language and Hearing Tests - The ISHA battery -1990. Mysore: Indian Speech and Hearing Association; 1990
    Google Scholar
  • 13 Jerger J. Clinical experience with impedance audiometry. Arch Otolaryngol 1970; 92 (04) 311-324
    CrossrefPubMedGoogle Scholar
  • 14 Dhar S, Hall JW. Otoacoustic Emissions: Principles, Procedures, and Protocols. San Diego: Plural Publishing; 2011
    Google Scholar
  • 15 Hall JW. New e-Handbook of Auditory Evoked Potential. Pearson Education, Inc.; 2015. DOI: 10.1001/archotol.1982.00790570061015
    CrossrefGoogle Scholar
  • 16 Rajasekaran AK, Arivazhagan A, Yuvaraj P, Shivashankar N. Audiovestibular findings in a 6 year old child with pilocytic astrocytoma - a case report. Int J Audiol 2020; 59 (03) 236-241
    CrossrefPubMedGoogle Scholar
  • 17 Wang SJ, Jaw FS, Young YH. Ocular vestibular-evoked myogenic potentials elicited from monaural versus binaural acoustic stimulations. Clin Neurophysiol 2009; 120 (02) 420-423
    CrossrefPubMedGoogle Scholar
  • 18 Lee KJ, Kim MS, Son EJ, Lim HJ, Bang JH, Kang JG. The usefulness of rectified VEMP. Clin Exp Otorhinolaryngol 2008; 1 (03) 143-147
    CrossrefPubMedGoogle Scholar
  • 19 Welgampola MS, Colebatch JG. Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology 2005; 64 (10) 1682-1688
    CrossrefPubMedGoogle Scholar
  • 20 Jahner JA, Schlauch RA, Doyle T. A comparison of American Speech-Language Hearing Association guidelines for obtaining speech-recognition thresholds. Ear Hear 1994; 15 (04) 324-329
    CrossrefPubMedGoogle Scholar
  • 21 Jerger J, Jerger S. Diagnostic significance of PB word functions. Arch Otolaryngol 1971; 93 (06) 573-580
    CrossrefPubMedGoogle Scholar
  • 22 Rance G, Ryan MM, Bayliss K, Gill K, O'Sullivan C, Whitechurch M. Auditory function in children with Charcot-Marie-Tooth disease. Brain 2012; 135 (Pt 5): 1412-1422
    CrossrefPubMedGoogle Scholar
  • 23 Seeman P, Mazanec R, Huehne K, Suslíková P, Keller O, Rautenstrauss B. Hearing loss as the first feature of late-onset axonal CMT disease due to a novel P0 mutation. Neurology 2004; 63 (04) 733-735
    CrossrefPubMedGoogle Scholar
  • 24 Rance G, Starr A. Pathophysiological mechanisms and functional hearing consequences of auditory neuropathy. Brain 2015; 138 (Pt 11): 3141-3158
    CrossrefPubMedGoogle Scholar
  • 25 Guilbot A, Williams A, Ravisé N. et al. A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 2001; 10 (04) 415-421
    CrossrefPubMedGoogle Scholar
  • 26 Isaradisaikul S, Navacharoen N, Hanprasertpong C, Kangsanarak J. Cervical vestibular-evoked myogenic potentials: norms and protocols. Int J Otolaryngol 2012; 2012: 913515
    CrossrefPubMedGoogle Scholar
  • 27 Rosengren SM, Govender S, Colebatch JG. Ocular and cervical vestibular evoked myogenic potentials produced by air- and bone-conducted stimuli: comparative properties and effects of age. Clin Neurophysiol 2011; 122 (11) 2282-2289
    CrossrefPubMedGoogle Scholar
  • 28 Bandini F, Beronio A, Ghiglione E, Solaro C, Parodi RC, Mazzella L. The diagnostic value of vestibular evoked myogenic potentials in multiple sclerosis. J Neurol 2004; 251 (05) 617-621
    CrossrefPubMedGoogle Scholar
  • 29 Gazioglu S, Boz C. Ocular and cervical vestibular evoked myogenic potentials in multiple sclerosis patients. Clin Neurophysiol 2012; 123 (09) 1872-1879
    CrossrefPubMedGoogle Scholar
  • 30 Gillespie CS, Sherman DL, Fleetwood-Walker SM. et al. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 2000; 26 (02) 523-531
    CrossrefPubMedGoogle Scholar
  • 31 Itoh A, Kim YS, Yoshioka K. et al. Clinical study of vestibular-evoked myogenic potentials and auditory brainstem responses in patients with brainstem lesions. Acta Otolaryngol Suppl 2001; 545 (545) 116-119
    Google Scholar
  • 32 Sartucci F, Logi F. Vestibular-evoked myogenic potentials: a method to assess vestibulo-spinal conduction in multiple sclerosis patients. Brain Res Bull 2002; 59 (01) 59-63
    CrossrefPubMedGoogle Scholar
  • 33 Murnane OD, Akin FW, Kelly KJ, Byrd S. Effects of stimulus and recording parameters on the air conduction ocular vestibular evoked myogenic potential. J Am Acad Audiol 2011; 22 (07) 469-480
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Ponzo S, Kirsch LP, Fotopoulou A, Jenkinson PM. Balancing body ownership: Visual capture of proprioception and affectivity during vestibular stimulation. Neuropsychologia 2018; 117: 311-321
    CrossrefPubMedGoogle Scholar
  • 35 Scherer H, Clarke AH. Vestibular System. International Encyclopedia of the Social & Behavioral Sciences. 2001: 16170-16176
    Google Scholar
  • 36 van der Linden MH, van der Linden SC, Hendricks HT, van Engelen BG, Geurts AC. Postural instability in Charcot-Marie-Tooth type 1A patients is strongly associated with reduced somatosensation. Gait Posture 2010; 31 (04) 483-488
    CrossrefPubMedGoogle Scholar
  • 37 Tramontani O, Gkoritsa E, Ferekidis E, Korres SG. Contribution of vestibular-evoked myogenic potential (VEMP) testing in the assessment and the differential diagnosis of otosclerosis. Med Sci Monit 2014; 20: 205-213
    CrossrefPubMedGoogle Scholar